iCAD Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2019

NEXT STORY
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
PREV STORY
Curetis To Attend Key Conferences in the Fourth Quarter of 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Electrosurgery Market to reach US $6.7 billion by 2025 – Global Insights on Trends, Size, Price Trend Analysis, Value Chain analysis, Key Drivers, and Future Prospect: Adroit Market Research

author_avatar
NASDAQ Market News

Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Hemispherx Secures Corrections from Two Stock News Organizations Related to Their Inaccurate Reporting of an Equity Distribution Agreement Disclosed in a Recent SEC Filing

author_avatar
NASDAQ Market News